ciprofloxacin has been researched along with deoxycholic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Garg, D; Gupta, GK; Jain, V; Keshava, GB; Mishra, PR; Shukla, PK; Shukla, R; Singodia, D | 1 |
| Mishra, PR | 1 |
| Mavri, A; Smole Možina, S | 1 |
| Jain, V; Mishra, PR; Pal, R; Shukla, P | 1 |
7 other study(ies) available for ciprofloxacin and deoxycholic acid
| Article | Year |
|---|---|
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Ciprofloxacin surf-plexes in sub-micron emulsions: a novel approach to improve payload efficiency and antimicrobial efficacy.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cell Line; Chitosan; Ciprofloxacin; Deoxycholic Acid; Emulsions; Escherichia coli; Excipients; Hydrophobic and Hydrophilic Interactions; Macrophages; Male; Mice; Mice, Inbred BALB C; Particle Size; Pseudomonas aeruginosa; Staphylococcus aureus; Surface-Active Agents; Viscosity | 2011 |
An investigation on the approach to target lipopolysaccharide through polymeric capped nano-structured formulation for the management of sepsis.
Topics: Animals; Anti-Infective Agents; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Compounding; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Nanocapsules; Sepsis; Treatment Outcome | 2011 |
Resistance to bile salts and sodium deoxycholate in macrolide- and fluoroquinolone-susceptible and resistant Campylobacter jejuni and Campylobacter coli strains.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Deoxycholic Acid; Dipeptides; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Piperazines; Poultry; Swine | 2013 |
Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.
Topics: Animals; Anti-Bacterial Agents; Cations; Chitosan; Ciprofloxacin; Deoxycholic Acid; Drug Carriers; Emulsions; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Microbial Sensitivity Tests; Nanostructures; Particle Size; Peritonitis; Rats, Wistar; Sepsis; Technology, Pharmaceutical | 2014 |